European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on November 3, 2026

Nov. 3, 2026

The ReFrame™ Launches to Help Consumer Brands Turn Women’s Economic Power Into Growth

Indeterminate EIN Presswire

Nov. 3, 2026

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

Indeterminate GlobeNewswire

Nov. 3, 2026

Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities

Indeterminate GlobeNewswire

Nov. 3, 2026

Maze Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Parabilis Medicines to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

NexGold Intersects 4.16 g/t Gold over 7.0 Metres, 2.84 g/t Gold over 7.0 Metres and 1.94 g/t Gold over 9.0 Metres in RC Infill Drill Program at the Goldboro Gold Project, Nova Scotia

Indeterminate GlobeNewswire

Nov. 3, 2026

Sportradar Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 3, 2026

Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November

Indeterminate GlobeNewswire

Nov. 3, 2026

Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%

Indeterminate GlobeNewswire

Nov. 3, 2026

QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform

Indeterminate GlobeNewswire

Nov. 3, 2026

InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day

Indeterminate GlobeNewswire

Nov. 3, 2026

BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2026 sowie Informationen zur Geschäftsentwicklung

Indeterminate GlobeNewswire

Nov. 3, 2026

BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Azimut Undertakes New Mineral Resource Estimate on the Patwon Gold Deposit, James Bay Region, Québec

Indeterminate GlobeNewswire

Nov. 3, 2026

Azimut entreprend une nouvelle estimation des ressources minérales du gîte d’or Patwon, région de la Baie James, Québec 

Indeterminate GlobeNewswire

Nov. 3, 2026

STRONG MIX AND PERSONALIZATIONS SUSTAIN Q3 GROWTH AND FURTHER 2026 GUIDANCE UPGRADE

Indeterminate GlobeNewswire